Complete Response in a Patient With Chemorefractory EGFR-Amplified, PD-L1-Positive Metastatic Gastric Cancer Treated By Dual Anti-EGFR and Anti-PD-1 Monoclonal Antibody Therapy.

ABSTRACT:

SUBMITTER: Reizine N 

PROVIDER: S-EPMC7670563 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature